trending Market Intelligence /marketintelligence/en/news-insights/trending/Dm7SjvcuL2D6oOMFjs4xXA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Maricann Group appoints CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Maricann Group appoints CFO

Maricann Group Inc. appointed Scott Langille as CFO, effective Oct. 2, subject to regulatory approval.

Previously, the company's CEO Ben Ward had taken the additional role of interim CFO.

Langille was formerly CFO of Tribute Pharmaceuticals Canada Inc., which was sold to Pozen Inc. in February 2016 for $160 million to form Aralez Pharmaceuticals Inc.